Pharmacologic opportunities for HIV prevention

MR Nicol, ADM Kashuba - Clinical Pharmacology & …, 2010 - Wiley Online Library
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV骾nfected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …
被引用次数：38 相关文章

Pharmacologic opportunities for HIV prevention.

MR Nicol, ADM Kashuba - 2010 - cabidigitallibrary.org
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …

Pharmacologic Opportunities for HIV Prevention.

MR Nicol, ADM Kashuba - Clinical Pharmacology & …, 2010 - search.ebscohost.com
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …

Pharmacologic opportunities for HIV prevention

MR Nicol, ADM Kashuba - Clinical pharmacology and …, 2010 - experts.umn.edu
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …

[引用][C] Pharmacologic Opportunities for HIV Prevention

MR NICOL, ADM KASHUBA - Clinical pharmacology and …, 2010 - pascal-francis.inist.fr
Pharmacologic Opportunities for HIV Prevention CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …

Pharmacologic opportunities for HIV prevention.

MR Nicol, AD Kashuba - Clinical Pharmacology and Therapeutics, 2010 - europepmc.org
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …
[PDF] researchgate.net

[PDF][PDF] Pharmacologic Opportunities for HIV Prevention

MR Nicol, ADM Kashuba - Clin Pharmacol Ther, 2010 - researchgate.net
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …

Pharmacologic Opportunities for HIV Prevention

MR Nicol, ADM Kashuba - Clinical Pharmacology & Therapeutics …, 2010 - cdr.lib.unc.edu
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …

Pharmacologic opportunities for HIV prevention

MR Nicol, ADM Kashuba - Clinical pharmacology and …, 2010 - pubmed.ncbi.nlm.nih.gov
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …
[HTML] nih.gov

[HTML][HTML] Pharmacologic Opportunities for HIV Prevention

MR Nicol, ADM Kashuba - Clinical pharmacology and therapeutics, 2010 - ncbi.nlm.nih.gov
Innovations in antiretroviral (ARV) treatment strategies have resulted in treated HIV-infected
patients having life expectancies similar to those of uninfected individuals. Yet the number of …